Jiangsu Hengrui Pharmaceuticals Co., Ltd.SSE: 600276

(600276)"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Announcement on Progress in Repurchasing A-Shares

· Issued by Jiangsu Hengrui Pharmaceuticals Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 600276 · · 2 pages · Chinese

Summary by 6ix AI

Jiangsu Hengrui Pharmaceuticals Co., Ltd. has announced progress on its A-share repurchase plan. The repurchase is part of a strategy to implement an employee stock ownership plan and maintain shareholder value. The announcement includes details on the repurchase price range and total amount spent so far.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Jiangsu Hengrui Pharmaceuticals Co., Ltd. on 6ix

Story so far

Earlier from Jiangsu Hengrui Pharmaceuticals

Later from Jiangsu Hengrui Pharmaceuticals

All Jiangsu Hengrui Pharmaceuticals news releases